Free delivery to Riyadh, Jeddah, Abha on orders over 100 SAR.
ÂÂ
Trulicity contains dulaglutide. This human GLP-1 receptor agonist activates these receptors in beta cells in the pancreas, stimulating insulin secretion, and helps reduce glucagon levels and slow down food emptying.
Trulicity is used to treat type 2 diabetes, especially in patients with 10 years or more of diabetes without being able to control blood sugar levels.
ÂÂ
Trulicity may be used alone in treatment, or along with some other prescribed medications for diabetics.
The doctor shall determine the appropriate dose.
The prescribed dose must be adhered to by the doctor.
Maximum allowable dose is 4.5 mg per week.
The drug is injected under the skin in the abdomen, thigh, or upper arm.
The drug is neither used by intravenous nor intramuscular injections.
Trulicity may cause some side effects, such as:
Low blood sugar levels (especially when used with insulin or other diabetes drugs).
Nausea.
Vomiting.
Diarrhea.
Abdominal pain.
anorexia.
fatigue.
Trulicity is not used in the case of:
Allergy to drug ingredients.
The patient or a family member has previously had medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2.
The drug may cause pancreatitis, in which case it should be discontinued.
The use of the drug along with insulin may lead to a drop in blood sugar levels, so the dose of insulin or other drugs used along with Trulicity should be reduced.
The doctor should be consulted before using the drug for patients with kidney or liver, to adjust the appropriate dose for them.
The doctor should be consulted before using Trulicity during pregnancy.
The doctor should be consulted before using Trulicity during breastfeeding.